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1.1. Drug resistance mechanisms 
Cancer chemotherapy is limited by MDR (multidrug resistance) based on known 
biochemical mechanisms. MDR1 also called P-gp transporter is the most important efflux 
mechanism, which has role in development of cancer multidrug resistantce. Beside efflux 
mechanisms the intracellular drugresitance can be classified as follows:  
1. Alteration in drug target 
2. Increasing in DNA repair mechanisms 
3. Defective apoptotic pathways. 
4. Reduced intracellular accumulation: It is in association with overexpression of 
ABC transporters 
 
1.2.  ABC transporters 
Over 200 proteins are involved in the transport of substrates accross biological 
membranes are members of the ABC (ATP-binding cassette) superfamily of proteins. 
The most common member of ABC transporter is the 170 kDa multidrug resitance 
protein 1 (MDR1) also called P-glycoprotein (P-gp). The second distantly related ABC 
protein, the 190-kDa multidrug resistance related protein 1 (MRP1) facilitated the 
discovery of eight more genes within the same ABC subfamily. A third drug transporter, 
also distantly related to P-glycoprotein and the MRPs, is the breast cancer resistance 
protein (BCRP). Although the lung resistance protein (LRP) is not an ABC 
transporter, it is frequently included in discussions of drug resistance, as it is expressed 
at high levels in drug-resistant cell lines and some tumours.  
The clinical relevance of these proteins in multidrug resistance is not yet established 
except expression of MRP1 and P-glycoprotein which has been reported in a variety of 
hematological and solid tumors.  
 
1.3. MDR modulators 
The first generation of P-gp modulators transporter, including verapamil, cyclosporin 
(cyclosporin A), tamoxifen, and several calmodulin antagonists, were identified in the 
1980s.  
In vivo use of high doses from them resulting in unacceptable toxicity, moreover 
increased myelosupression, hyperbilirubinemia and altered disposition of the 
cytototoxins.  
The second generation P-gp modulators include dexverapamil, dexniguldipine, 
valspodar (PSC 833), and biricodar (VX-710). These agents are more potent than their 
predecessors and also less toxic. Second-generation P-gp inhibitors have a better 
pharmacologic profile than the first generation compounds, but they also retain some 
characteristics that limit their clinical usefulness.  
The third generation have high specifity for P-gp and not to other ABC transporters. 
The third generation P-gp inhibitors currently in clinical development include the 
tariquidar, zosuquidar and laniquidar. 
 
1.4. MRP modulators 
Agosterol A is a natural polyhydroxylated sterol. Few of its analogues were found to be 
powerful modulators. 
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Flavonoids have been largely explored as modulators of P-gp-mediated MDR. In the 
last few years, a growing number of reports have been published concerning the use of 
dietary flavonoids as MRP1 inhibitors. 
The nonsteroidal estrogen receptor mixed agonist/antagonist, raloxifene was used 
as a pharmacophore model to conceive selective modulators of MRP1-mediated MDR.  
Antiinflammatory drug, indomethacin chemosensitized MRP1-overexpressing cells.  
 
Despite the fact that large numbers of chemicals were synthesized and evaluated, there 
is no resistance modifier to-date in the medical practice. Natural compounds of edible 
plants and vegetables are expected to be incomparably less toxic on normal cells, 
tissues of the host than synthetic compounds. Consequently, jatrophane diterpenes 
carotenoids and flavonoids were promising to study their MDR reversing effect on 
various tumor cell lines with multidrug resitance.  
 
2 .  A I M S  O F  T H E  S T U D Y  
 
The aim of our study was to examine new perspectives of chemotherapy in connection 
with modification of multidrug resistance of cancer by inhibiton of MDR1 and MRP. Our 
purpose was to find a less toxic multidrug resistant reversal agent than verapamil, 
valspodar or tariquidar among synthethic organosilicons and natural plant derivative 
carotenoids, flavonoids, tri- and diterpenoid compounds. 
Main goals of the study in details: 
1. Examined cell lines were characterized to multidrug resistant properties by 
immuncytochemistry 
2. Antiproliferative effects of  potential resistant modifiers were studied 
3. MDR reversal effect of organosilicon, terpenoid (jatrophane diterpens and 
carotenoids) and flavonoid compounds was systematically studied by human mdr1 
gene transfected mouse lymphoma cell line 
4. Reversal of MDR was also studied on drug resistant human breast cancer cell line 
KCR by carotenoid compounds 
5. Reversal of MRP was investigated on human breast cancer cell line MDA-MB-231 
(HTB-26) by terpenoid (jatrophane diterpens and carotenoids) and flavonoid 
compounds. 
6. Reversal of multidrug resistance by organosilicon compounds on human larynx 
cancer Hep2C cell line 
7. Combination of possible resistance modifiers and anticancer drugs in vitro was 
examined by checkerboard microplate method. 
8. Comparison of the structure – activity relationship by physico-chemical parameters 
of carotenoids was analyzed by Computer model ADME/Boxes (computer program 
Adsorption, Distribution, Metabolism, Excretion).  
9. Apoptosis induction as additional contributing factor of induced cancer cell death. 
 
3 .  M A T E R I A L S  A N D  M E T H O D S  
 
3.1. Chemicals 
Synthetic compounds  
Compounds alis-409 (1,3-dimethyl-1,3-p-fluorophenyl-1,3(3-morfolinopropyl)-1,3 
disiloxan dihydrochlorid) and alis-421 (1,3-dimethyl-1,3-(4-fluorophenyl)-1,3-[3(4-buthyl)-
(1piperazinyl)-propyl]-1,3-disiloxan-tetrahydrochlorid). The silicion substituted alis 
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compounds were dissolved in DMSO by preparing stock solutions at a concentration 1.0 
mg/ml.  
Natural compounds:  
Macrocyclic diterpenes of the jatrophane type and rearranged polycyclic derivatives 
were involved in the study as follows:  
(1) pubescene A (3β,9α,15β-triacetoxy-7β-benzoyloxy-14-oxojatropha-5E,12E-diene); 
(2) pubescene B (3β,9α,15β-triacetoxy-7β-butanoyloxy-14-oxojatropha-5E,12E-diene); 
(3) pubescene C (3β,9α-diacetoxy-7β-benzoyloxy-15β-hydroxy-14-oxojatropha-5E,12E-
diene); (4) pubescene D (3β,9α-diacetoxy-7β-benzoyloxy-15β-hydroxy-14-oxo-2βH-
jatropha-5E,12E-diene); (5) 1b,5a,14a,17a-tetraacetoxy-3b-benzoyloxy-15b-hydroxy-9-
oxo-paraliane; (6) portlandicine (2a,5a,14a,17a-tetraacetoxy-3b-benzoyloxy-15b-
hydroxy-9-oxo-paraliane; (7) segetalol-1,5,14-triacetate-3-benzoate;   (8) 
euphopubescenol [5α,8α,15β-triacetoxy-3α-benzoyloxy-4α-hydroxy-9,14-dioxo-13βH-
jatropha-6(17),11E-diene]; (9) euphopubescene (3β,7β,8β,9α,14α,15β-hexaacetoxy-
2βH-jatropha-5E,11E-diene); (10) pubescenol [5α, 8β,15β-triacetoxy-3β-benzoyloxy- 
4α-hydroxy-9,14-dioxo-13βH-jatropha-6(17),11E-diene]. All compounds were dissolved 
in DMSO.  
Carotenoids: Lycopene, capsanthin, capsorubin, antheraxanthin, violaxanthin, α-
carotene, β-carotene, α-cryptoxanthin, β-cryptoxanthin, zeaxanthin, lutein, neoxanthin, 
violeoxanthin, apple peel phytoxanthins and lycophill were isolated and identified earlier 
by our group and were taken from our store. In case of the newly isolated and identified 
carotenoids mutatochrome, aurochrome, flavoxantin, chrisanthemaxanthin, monoepoxy-
β-carotene, diepoxy-β-carotene, 15,15`-dehydro-diepoxy-β-carotene, monoepoxy-α-
carotene, capsochrome “upper” epimer, from natural (anti)-capsanthin-5,6-epoxide, 
capsochrome “lower” epimer, from natural (anti)-capsanthin-5,6-epoxide, capsochrome 
“upper” epimer,from semisynthetic (syn) capsanthin-5,6-epoxid, capsochrome 
“lower”epimer from semisynthetic (syn) capsanthin-5,6-epoxid, lutechrome, (8’R)-
luteoxanthin, (8’S)-luteoxanthin, (13Z)-lutein (13’Z)-lutein, (13Z)-zeaxanthin, (9Z)-
violaxanthin and (9’Z)-neoxanthin. Stock solutions were prepared in DMSO. 
Flavonoids: Rotenone, catechin, neohesperidin, naringin, chrysin, robinin, floretin, 
floridzin, robinetin, dihydrorobinetin, kaempferol, dihydrofisetin, dihydroquercetin, 
sakuranin and sakuratenin were provided by Sándor Antus, Department of Organic 
Chemistry, University of Debrecen, Hungary. Formononetin, amorphigenin, afrormosin, 
6a,12a-dehydroamorphigenin and (+)-12-hydroxyamorphigenin were provided by Judit 
Hohmann, Department of Pharmacognosy, Faculty of Pharmacy, Albert Szent-Györgyi 
Medical Center, University of Szeged, Hungary. Epigallocatechin was purchased from 
Sigma (St Louis, MO, USA). All of the tested compounds were dissolved in 
dimethylsulfoxide (SERVA, Feinbiochemica, Heidelberg, Germany). 
  
3.2. Cell cultures  
3.2.1. L5178 mouse T-cell lymphoma cells  
3.2.2. Drug-resistant subline of breast cancer MCF7/KCRcells and its 
parental cell line  
3.2.3. Breast cancer MDA-MB-231 (ATCC: HTB-26) cells  
3.2.4. Hep2 (ATCC: CCL-23) pharyngeal carcinoma cell line 
  
3.3. Immunocytochemistry 
Cells were harvested and resuspended in serum-free media; the density of the cell 
suspension was 5×105 /ml. One hundred µl was cytocentrifugated for 5 minutes on 1000 
rpm. The samples were fixed in 4°C acetone for 10 minutes and were washed in TBS 
buffer (pH 7, 6) for 5 minutes. Endogenous peroxidases were quenched in 0.3% H2O2 for 
 5
15 minutes. The samples were incubated with primary antibodies (MRP: MRPm6, 
monoclonal (ICN), P-gp: NCL-PGLYm, monoclonal (Novocastra) in suitable dilutions 
(1:5, 1:10, 1:20) for one hour at room temperature. 
The samples were washed in TBS buffer for 3×5 minutes and were incubated with the 
secondary antibody (DAKO EnVisionTM System, CA, USA) for 30 minutes. The samples 
were washed in TBS for 3×5 minutes. Diaminobenzidin (DAKO, CA, USA) was used as 
the chromogen. Sections were counterstained with haematoxylin and mounted. 
 
3.4. Assay for antiproliferative and cytotoxic effect 
The effects of increasing concentrations of the drugs alone on cell growth were tested in 
96-well flat-bottomed microtiter plates. The compounds were diluted in a volume of 50 
L medium. Then, 1×104 cells in 0.1 mL of medium were added to each well, with the 
exception of the medium control wells. The culture plates were further incubated at 37 °C 
for 72 h. (In case of cytotoxicity test the cell number were 3×104 and the incubatuion 
time was 24 h.) At the end of the incubation period, 20 µL of MTT (thiazolyl blue, Sigma, 
St Louis, MO, USA) solution (from a 5 mg/mL stock) was added to each well. After 
incubation at 37 °C for 4 h, 100 µL of Sodium dodecyl sulfate (SDS) (Sigma, St Louis, 
MO, USA) solution (10%) was measured into each well and the plates were further 
incubated at 37 °C overnight. The cell growth was determined by measuring the optical 
density (OD) at 550 nm (ref. 630 nm) with a Dynatech MRX vertical beam ELISA reader. 











3.5. Assay for reversal of MDR in mouse lymphoma cells 
 The L5178 MDR and L5178Y parent cell lines were grown in McCoy’s 5A medium 
containing 10% heat-inactivated horse serum, L-glutamine and antibiotics. The cells 
were adjusted to a density of 2×106/mL, resuspended in serum-free McCoy’s 5A 
medium and distributed in 0.5-mL aliquots into Eppendorf centrifuge tubes. The tested 
compounds were added at various concentrations in different volumes (2.0-20.0 µL) of 
the 1.0-10.0 mg/mL stock solutions and the samples were incubated for 10 min at room 
temperature. Next, 10 µL (5.2 µM final concentration) of the indicator rhodamine 123 
(Sigma, St Louis, MO, USA) was added to the samples and the cells were incubated for 
a further 20 min at 37 °C, washed twice and resuspended in 0.5 mL PBS for analysis. 
The fluorescence of the cell population was measured with a Beckton Dickinson 
FACScan flow cytometer. Verapamil (EGIS, Hungarian Pharmaceutical Company, 
Budapest, Hungary) was used as a positive control in the rhodamine 123 exclusion 
experiments. The percentage mean fluorescence intensity was calculated for the treated 
MDR and parental cell lines as compared with the untreated cells. An activity ratio R was 
calculated via the following equation on the basis of the measured fluorescence values: 
 
controlparentaltreatedparental
controlMDRtreatedMDRR =  
 
3.6. Assay for reversal of MDR drug-resistant subline of breast cancer MCF7 cells 
See at assay for reversal of MDR in mouse lymphoma cells. 
 
3.7. Reversal of MRP in the MDA-MB-231 (HTB-26) human brest cancer cell line 
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 The cells were distributed onto a 6-well plate, each well containing 2.5×105 cells in 5 mL 
of culture medium. These cells were grown for 72 h for the experiment. The culture 
medium was then changed to 1 mL of serum-free medium per well and the tested 
compounds were added in various amounts (4-40 L) from a  1.0 mg/mL stock solution, 
and the cells were incubated for 10 min at room temperature. Next 10 L of 2’,7’-bis(2-
carboxyethyl)-5(6)-carboxy-fluorescein acetoxymethyl ester (BCECF-AM) (Sigma, St 
Louis, MO, USA) was added to the samples, to give a final concentration  of 2.6 M, and 
the cells were then incubated for a further 20 min at 37 °C, next washed in phosphate-
bufferd saline (PBS) and detached with trypsin-versen solution {0.25%(w/v) trypsin – 
0.03%(w/v) EDTA} to harvest the cells from the 6-well plate. The cells from each well 
were transferred to Eppendorf centrifuge tubes and washed once in culture medium and 
PBS. The samples were resuspended in 0.5 mL of PBS for measurement. The 
fluorescence of the cell population was analyzed by flow cytometry using a Beckton 
Dickinson FACScan instrument. Indomethacin (Sigma, St Louis, MO, USA) in a  final 
concentration of 20 M was used as a positive control in the experiments. The 
fluorescence activity was determined as the ratio of the fluorescence activities of treated 
and untreated samples. 
 
3.8. Checkerboard microplate method as model for combination therapy 
 It was applied to study the effects of drug interactions between resistance modifiers and 
cytotoxic compound on cancer cells. 
The effects of the anticancer drug epirubicin and the resistance modifiers in 
combination were studied on various cancer cell lines. The dilutions of epirubicin (A) 
were made in a horizontal direction, and the dilutions of resistance modifiers (B) 
vertically in the microtiter plate in 100L volume. The cell suspension in the tissue 
culture medium was distributed into each well in 100 µL containing 5×104 cells. The 
plates were incubated for 72 h at 37 °C in a CO2 incubator. The cell growth rate was 
determined after MTT staining and the intensity of the blue color was measured on a 
micro ELISA reader. Drug interactions were evaluated according to the following system: 
 
 
FICA= ID50A in combination / ID50A alone 
FICB= ID50B in combination / ID50B alone 
ID=inhibitory dose 
FIC=fractional inhibitory concentration 
FIX=fractional inhibitory index 
FIX = FICA+FICB 
FIX = 0.51-1Additive effect 
FIX < 0.5 Synergism 
FIX=1 - 2 Indifferent effect 
FIX > 2 Antagonism 
 
3.9. The prediction of P-glycoprotein substrate specificity for clinical studies 
For tested compounds values of Hydrogen donors, Hydrogen acceptors, Abraham’s 
alpha, Abraham’s beta, total polar surface area (TPSA), logP and McGowan volume 
were calculated by ADME/Boxes (computer program) available from Pharma Algorithms 
Inc., 2004 Canada; www-ap-algorithms.com. 
 
4 .  R E S U L T S  
4.1. Immuncytochemistry of cell lines 
The presence of MRP on MDA-MB 231 was detected by 
immunocytochemistry with MRPm6, monoclonal antibody. High level of P-gp expression 
was also detected on the membrane of L5178Y human mdr1 transfected mouse 
lymphoma cells and on the membrane surface of the drug-resistant subline of MCF7 
(KCR) by NCL-PGLYm mouse monoclonal antibody. High expression of both MDR1 and 
MRP proteins were detected on cell surface of human larynx carcinoma Hep2C cell line 
by the above mentioned antibodies. 
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4.2. Antiproliferative and cytotoxic effect of potential resistant modifiers 
It is suggested to decrease the toxicity of possible resistance modifiers that is why it is 
important to know the antiproliferative and toxic property of different compounds before 
in vitro combination. The antiproliferative effect and cytotoxic effect are very different, in 
case of organosilicon, terpenoid and flavonoid derivatives, generally the human mdr1 
gene transfected mouse lymphoma is more sensitive than human cancer cell lines.  
 
4.3. Reversal of multidrug resistance on mouse lymphoma 
Pubescences A-D were shown to enhance drug retention in the cells by inhibiting the 
efflux-pump activity mediated by P-glycoprotein. The results showed concentration 
dependence for all the compounds. Pubescene A and D exhibited the highest effect in 
reversing MDR activity and manifold activity, when compared to that of the positive 
control verapamil.  
Alpha- and beta-carotene exhibited no effect. The most effective compounds were 
capsanthin, lycophyll and capsorubin. Moderately effective carotenoids were 
violaxanthin, lycopene, lutein, zeaxanthin and antheraxanthin.  
Hydroxylation on the left ring in case of capsanthin and capsorubin a hydroxylation on 
the right five membered ring possibly responsible for the very high resistance reversal 
effect on the human MDR1 gene transfected mouse lymphoma cells.  
Treatment of the cancer cells with flavoxanthin, + chrysanthemaxanthin mixture and 
capochromes resulted in an extremely high fluorescence activity ratio. Different isomers 
of luteoxanthin and (Z)-carotenoids (cis-carotenoids) exhibited a high fluorescence 
activity ration on mouse lymphoma cells, however structurally related luteochrome was 
hardly effective as a reversing agent. 
When flavonoids were tested on the mouse lymphoma cells, rotenone, chrysin, floretin 
and epigallocatechin displayed a dose-dependent increase in the fluorescence activity 
ratio (FAR). Dihydroquercetin, dihydrofisetin, dihydrorobinetin and floridzin reduced the 
rhodamine 123 accumulation in the cells.  
Of the isoflavonoids, amorphigenin and formononetin proved to have the strongest MDR-
reversal effects. 
 
4.4. Reversal of multidrug resistance on doxorubicine selected drugresistant 
subline of MCF7 (KCR) 
When the carotenoid isomers were tested on KCR cell line, much less inhibition of MDR 
efflux pumps was found than for the human mdr1 gene transfected mouse lymphoma 
cells in the presence of the carotenoids.  
 
4.5. Reversal of MRP on breast cancer cell line MDA-MB-231 (HTB-26)  
R123 accumulation was very low in case of 1 and 4 it was only 20%. However the 
presence of MDR1 was detected by specific monoclonal antibody but it seems that this 
protein remained ineffective, because neither verapamil nor pubescences could enhance 
the fluorescence activity ratio. 
The same compounds were tested on MRP, the carboxyfluorescein (BCECF-AM) 
accumulation of the MDA-MB-231 breast cancer cells was measured. Increased 
fluorescence activity was shown by some compounds such as 1, 8, 9.  
When the carotenoid compounds were tested on MRP, the carboxyfluorescein 
accumulation of the MDA-MB-231 breast cancer cells was measured. Several 
compounds like mutatochorme, 15-15'dehidroβcarotene, monoepoxy-α-carotene, (8’S)-
luteoxantin and (13Z)-lutein (13’Z)-lutein caused higher accumulation than positive 
control indometacin.  
Chrysin, robinin, kaempferol, dihydroquercetin and epigallocatechin were as effective as 
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the indometacin control, elevating the BCECF-AM accumulation by 20-60%. Rotenone, 
catechin and sakuranin reduced the drug accumulation in the cells, because of their 
toxical effect. 
Among isoflavonoids formononetin increased the drug accumulation in both cell lines as 
compared with the control. Afrormosin was only moderately effective on the MRP 
reversal of the tumor cells. 6a12a-Dehydroamorphigenin and (+)-12a-
hydroxyamorphigenin had only marginal effects as compared with indomethacin-treated 
MRP cells. 
 
4.6. Reversal of multidrug resistance by organosilicon compounds on human 
larynx cancer Hep2C cell line 
Apparently the rhodamine and carboxyfluorescein accumulation was increased in the 
presence of low concentration of Alis 409 remarkably while the rhodamine accumulation 
was increased moderately in the presence of 0.4 µg/ml Alis 409. In case of Alis 421 also 
the lower concentrations have higher activity, probably due to some toxical effect at 
higher concentration. 
 
4.7. In vitro combinations (checkerboard method) 
However in the short term accumulation assays the Alis compounds seemed to be 
ineffective in the longer combination. Both of them could enhanced the effect of 
epirubicin on human larynx cancer Hep2C cell line. 
Pubescene A showed the highest activity against efflux pump MRP however it had only 
moderate effect in longer in vitro combination assay on MDA-MB-231 cell line. 
Pubescenes A and D enhanced the effect of epirubicin on human mdr1 gene transfected 
mouse lymphoma cell line. 
Of the possible resistance modifiers (13Z)-zeaxanthin was able to enhance the 
antiproliferative effect of epirubicin synergistically on both cell lines. Luteoxanthin and 
(Z)-carotenoid treatment was also effective. Monoepoxy-β-carotene remained almost 
ineffective in combination treatment.  
Despite the relatively low degree of inhibition on the P-gp efflux pump of KCR human 
breastcancer cells, the combinations of epirubicin and some carotenoids resulted in 
synergism in the antiproliferative action of epirubicin. 
Carotenoids mutatochrome, 15-15'dehidro-β-carotene, monoepoxy-α-carotene and (8’S) 
Luteoxanthin which had higher activity of MRP inhibition were only moderately effective 
in vitro combination on MDA-MB-231 cell line. 
Of the resistance modifiers chrysin and amorphigenin were able to enhance the 
antiproliferative activity of epirubicin on mouse lymphoma cells. Rotenone significantly 
had only a marginal additive antiproliferative effect in combination with epirubicin. On the 
MDA-MB-231 breast cancer cell line, formononetin and kaempferol exhibited synergism.  
 
4.8. Comparison of the structure – activity relationship by physico-chemical 
parameters of carotenoids was analyzed by Computer model ADME/Boxes 
(computer program Adsorption, Distribution, Metabolism, Excretion)  
 
Based on the fluorescence activity ratio values and the chemical structures of the 
studied compounds some correlation was found between the resistance modifier action 
and physicochemical parameters of the tested compounds.  
In further analysis we decided which physico-chemical property is the most significant in 
describing MDR inhibitor capacity of tested carotenoids. Our finding that TPSA is one of 




5 .  D I S C U S S I O N  
 
In general P-gp can be inhibited on direct and indirect ways. Direct: a) blocking drug 
binding site either competitively, non competitively or allosterically, b) interfering ATP 
hydrolysis. Indirect: altering integrity of cell membrane lipids. 
Four groups of compounds were studied: organosilicon, jatrophane-type diterpenes, 
carotenoids, flavonoid derivatives. 
Some organosilicon compounds are well known cytostatic drugs: 2.6-cis-
diphenylcyclotetrasiloxane (Cisobitan) was found to be partially effective in the in vivo 
treatment of patients with prostate carcinoma.  
The high toxicity and side-effects of organosilicon compounds limited their application in 
the therapy of cancer. The possible application of organosilicon compounds is a new 
approach for the reversal of MDR. Alis 409 and Alis 421 display marked effectivity for 
reversal of the MDR of mdr-1 cells. Both P-gp and MRP inhibitory effects were low on 
human cancer cell lines in drug accumulation assay nevertheless significant synergism 
was observed in vitro combination of Alis compounds and epirubicin on human larynx 
carcinoma Hep2C cell line. 
Several derivatives of polyfunctional diterpenes isolated from Euphorbiaceae have been 
considered as potent inhibitors of multidrug resistance. The high anti-MDR potency of 
jatrophanes pubescene A and D which were also very effective in combination, indicated 
that this type of diterpenes are considered as a new chemotype of P-gp inhibitors. 
Moreover Pubescene D has significant affinity both MRP and MDR inhibition. 
Recently, G. Corea's group also reported jatrophane diterpenes from Mediterranean 
Euphorbia species as powerful MDR-modifier. The biological activities of the diterpenes 
were assayed through their ability to inhibit P-gp-mediated daunomycin efflux of cancer 
cells, related to cyclosporine A.  
Comparing certain pairs of the isolated compounds evidenced the importance of different 
part of the molecule, such as substitutions on ring A and at C-5, C-8, C-9, C-14 and C-
15.  
The MDR-reversing effects of the carotenoids tested in the present experiments 
exhibited a structure-activity relationship. It seems that the configuration of (Z) 
compounds has a stronger binding capacity toward the P-gp than the linear (all-E) forms.  
Recent studies suggest that the membrane structure may play a critical role in the MDR 
activities. It has also been suggested that polar carotenoids (e.g. lutein or zeaxanthin) 
generally being incorporated better than non-polar β-carotene. This phenomenon could 
explain the higher activity of polar carotenoids in MDR reversal. Moreover, polar 
carotenoids are preferentially located in the region of unsaturated lipids of the membrane 
and it may be presumed that there are differences in the ratio of saturated and 
unsaturated fatty acids in different cell lines, which may be responsible for the variation 
in the MDR-modulating effect of carotenoids on the mouse lymphoma and resistant 
MCF7 cell lines in our experiments.  
It is reported that the carotenoids partition into the hydrophobic core of the membrane 
and cause a decrease in lipid fluidity. The reduced membrane fluidity may sterically 
hinder diffusion of drugs and decrease the kinetics of drug excretion. 
While (Z) stereoisomeric form of carotenoids, seemed to be more effective on P-gp 
inhibition; they were ineffective on MRP inhibition which can also been explain by 
functional and structural differences of two efflux pumps.  
It seems that the most relevant factor among physico-chemical properties of carotenoids 
is TPSA total polar surface area, however is not enough in itself for prediction of P-gp 
inhibitory activity. 
Other studies have demonstrated that some dietary flavonoids may modulate organic 
anion and GSH transport, ATPase and drug resistance. In our experiments, chrysin and 
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rotenoid derivatives, had P-gp modulating activity. The most effective cell proliferation 
inhibitor was the mitochondrial electron transport inhibitor rotenone which also could be 
responsible for caspase dependent and independent cell death. With hydroxyl(-OH) 
group at the position of 29th carbon moderated the toxicity of amorphigenin compare to 
rotenone, although it has remained significant.  
The concentrations of the test compounds had great effects on the outcome of the 
experiments. A low concentration of quercetin, for an example, activated the activity of 
P-gp, whereas a high concentration inhibited that of P-gp.  
 
6 .  N E W  S T A T E M E N T S  
 
1. Detecting P-gp molecule by mABs is not always equal with increased efflux activity, P-
gp resistant phenotype of cancer cells, because in our experiments 
immunocytochemistry signed high presence of P-gp on MDA-MB-231, however in 
vitro experiments these proteins remained non-functional (or with very low activity) in 
comparison to  transfected cell line or other cells with acquired resistance. 
2.  Beside the human mdr1 gene transfected mouse lymphoma the organosilicon 
compounds seem to be effective on human Hep2 cell line with chemo and 
radioresistance. These results are encouraging, in vivo investigations are in progress 
with organosilicon compounds on Hep2C transplanted SCID mice. 
3. There is not enough data to draw for conclusion about the ideal structure of 
jatrophane diterpenes with the best P-gp inhibitory activity.The high anti-MDR 
potency of jatrophanes pubescene A and D were effective in combination with 
epirubicin in vitro, Pubescene D also had shown significant MRP inhibition. The 
results indicated that this type of diterpenes are considered as a new chemotype of 
MDR1 and MRP1 inhibitors, which can be regarded as promising lead compounds for 
drug development programs. 
4. It seems that the effect of carotenoids on MDR reversal and apoptotic effect of tumor 
cells depend on the chemical structure, polarity as well as membrane incorporation 
ability of carotenoid derivatives.  
5. The importance of computer analysis of structure-activity relationship (SAR) should be 
emphasized in connection with MDR reversal. In further P-gp reversal experiment also 
seems beneficial to use ADME computer program to predict the P-gp inhibitory 
probability to save money and time. 
6. While effective carotenoids interact in an indirect way with P-gp through membrane – 
lipid and protein interactions, flavonoids (rotenone and amorphigenin) would rather 
affect directly the ATP binding domain of protein. 
7. Membrane mediated mechanisms of MDR reversal through a putative modulation of 
membrane fluidity are likely to play a key role in reversal of resistance by carotenoids 
similarly to Tweens. Interaction of some carotenes change the membrane fluidity 
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